Status:
UNKNOWN
Propofol and Magnesium Sulfate Intravenous Infusion During Endoscopic Sinus Surgery
Lead Sponsor:
Mansoura University
Conditions:
Endoscopic Sinus Surgery
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Endoscopic Sinus surgery usually associated by bleeding, despite using of local vasopressor injection, head up position- controlled hypotension is generally used for control of this purpose. Propofol...
Detailed Description
The aim of the work to compare the efficacy of propofol and magnesium sulfate to control blood pressure during endoscopic sinus surgery and the resultant effects on the quality of the surgical field i...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists Physical Classes I or II
Exclusion
- Patients refusal
- Patients with hypersensitivity for any drug used in the study including magnesium, propofol or isoflurane
- Patients receiving magnesium sulfate supplementation
- Patients receiving drugs known to have significant interaction.
- Patients with ischemic heart disease
- Patients with heart defects
- Patients with significant heart failure
- Patients with increased intracranial pressure.
- Patients with systemic hypertension
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04078659
Start Date
September 1 2019
End Date
February 1 2020
Last Update
September 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nabil A Abd El-Mageed
Al Mansurah, DK, Egypt, 050